Clinician burnout rarely starts at the bedside. It builds quietly, in the minutes spent switching between platforms, hunting for documentation fields, and managing a growing stack of point solutions that don’t talk to each other. Teladoc Health is betting that consolidation, not addition, is what health systems actually need right now.
On October 7, 2026, the company announced two new AI-powered features inside Solo, its enterprise virtual care platform used across more than 15,000 care locations globally. The additions, SoloVitals and SoloScribe, are designed to bring patient data and clinical documentation directly into the virtual care workflow, without requiring new infrastructure or separate vendor relationships.
Contactless vital signs through a smartphone camera
SoloVitals uses remote photoplethysmography, or rPPG, to measure heart rate and respiration rate by analyzing subtle changes in facial skin color through a standard camera. No wearable, no peripheral device. A patient’s existing smartphone or tablet is enough.
The clinical case for contactless vitals in telehealth has been building for years, but adoption has been slow partly because most solutions exist outside the core care platform. By embedding measurement directly in Solo, Teladoc is positioning SoloVitals as something clinicians can actually use during a remote consultation, not as an add-on they have to remember to open. The company says the measurements are clinically validated, though independent peer-reviewed data will matter here as adoption grows. SoloVitals is currently in private preview with a full release expected in December 2026.
Ambient documentation that stays inside the workflow
SoloScribe is an ambient AI scribe that listens to virtual care visits and generates structured clinical notes within Solo. It supports both direct-to-patient video consultations and telemedicine device-based visits. When the encounter ends, a templated summary transfers into the EHR, with integrations already in place for Epic and Oracle Health via HL7 and FHIR standards. SoloScribe is generally available now.
Ambient scribing is no longer a novel concept. Products like Nuance DAX and Nabla have been gaining clinical traction for a couple of years. But most of these tools sit outside the virtual care workflow, which means clinicians still have to move between systems. Teladoc’s argument is about integration: one platform, one experience, less friction.
Why consolidation matters for health systems
Health systems are not short on AI tools. They are short on time to manage them. Each new solution brings its own onboarding process, security review, and workflow adjustment. The administrative overhead adds up fast, and clinical staff often bear the cost.
Teladoc’s broader pitch with Solo has always been about reducing that fragmentation. These two additions reflect a consistent strategy: extend what the platform already does rather than asking health systems to stitch together another vendor relationship.
- SoloVitals: contactless heart rate and respiration measurement via rPPG using a patient-side camera device
- SoloScribe: ambient AI documentation with structured note creation and EHR transfer via HL7 and FHIR
- Both embedded within Solo, available across eligible clinicians, programs, and virtual care workflows
- Solo is active in more than 15,000 care locations with existing Epic and Oracle Health integrations
The real test for both features is clinical uptake. Tools that reduce burden on paper often add it elsewhere during implementation. But the direction here is logical. If virtual care platforms want to remain central to how hospitals operate, they need to do more of the work, not less.